Success Stories: Japanese Postdoctoral Fellow Earns EB1A Approval for Groundbreaking Work in Cardiac and Neurodegenerative Disease Treatment

Client’s Testimonial:

“Thank you for supporting me very well.”

On October 2^nd, 2025, we received another EB1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the field of Integrative Healthcare Research (Approval Notice).

General Field: Integrative Healthcare Research

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: Japan

State of Residence at the Time of Filing: Ohio

Approval Notice Date: October 2^nd, 2025

Processing Time: 17 days (Premium Processing Requested)

Case Summary:

We are pleased to share the EB1A approval of a postdoctoral fellow from Japan whose pioneering work bridges neuroscience and cardiology. At the time of filing, the client was conducting advanced translational research on neurodegenerative and cardiovascular diseases, with a focus on Parkinson’s disease, atrial fibrillation, and cardiac device safety. Her impactful publication record, citation influence, and extensive peer review service established her as a distinguished candidate for EB1A approval.

Extraordinary Research Contributions

The client’s research integrates neuroscience and cardiology to advance medical care and patient safety. Her studies have revealed neuroprotective mechanisms in Parkinson’s disease, guided best practices for anticoagulation therapy after atrial fibrillation ablation, and provided some of the earliest large-scale assessments of leadless pacemaker safety. Collectively, her findings have advanced both scientific understanding and clinical practice, contributing to improved outcomes for patients worldwide.

Academic Record and Recognition

The client holds a Ph.D. in medical sciences and an M.D., combining clinical precision with research innovation. She has authored 28 peer-reviewed journal articles, 9 abstracts, and 1 book chapter, with work published in leading journals such as the European Heart Journal, Nature Communications, JACC: Clinical Electrophysiology, and Circulation: Arrhythmia and Electrophysiology. Her research has been cited 262 times by independent scholars across 37 countries, with several papers ranked among the top 1% of most-cited papers in clinical medicine.

She has also completed 27 peer reviews for major journals, including Heart Rhythm, BMC Public Health, and Scientific Reports, reflecting her recognition as a trusted expert in her field. Her research has informed international guidelines from the European Cardiac Arrhythmias Society and has been adopted by research teams at major universities and medical device companies, underscoring its global impact.

Expert Endorsements

Independent experts emphasized both the originality and the applied value of her work.
One recommender stated:

“Overall, [client]’s research provides insights that advance clinical decisions, hospital policies, and patient outcomes nationwide.”

This testimony reflects her influence as a researcher whose findings directly inform clinical innovation and healthcare policy.

EB1A Approval and Outlook

The I-140 EB1A petition was filed on September 15, 2025, and approved on October 2, 2025, under premium processing. USCIS recognized her publication record, citation impact, and the significant clinical relevance of her research as clear evidence of extraordinary ability.

With NAILG’s support, the client achieved EB1A approval and continues her research in the United States, where she is developing AI-driven models to predict disease outcomes and support new therapies. Her ongoing work strengthens U.S. leadership in precision medicine, bridging neuroscience, cardiology, and artificial intelligence to improve global health outcomes.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.